NCT01507207View on ClinicalTrials.gov

Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 15, 2015

Study Completion Date

May 15, 2015

Conditions
DysphagiaAspirationQuality of Life
Interventions
PROCEDURE

Injection laryngoplasty

Patients will undergo a direct microlaryngoscopy in the operating room for diagnostic purposes. In patients in whom laryngeal cleft is diagnosed, injection laryngoplasty will be carried out using sodium carboxymethylcellulose aqueous gel (commercial name Radiesse) injection material.

Trial Locations (1)

97239

Oregon Health & Science University - Doernbecher Children's Hospital, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT01507207 - Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft | Biotech Hunter | Biotech Hunter